Author: Adam Marcus

“False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

carboncoverThere’s a new retraction in the journal Carbon.

The case didn’t involve a Carbon copy — say, plagiarism or duplication — but rather an instance of fraud in a Japanese university, part of a larger case we covered last August.

Here’s the retraction notice for the paper, “The role of Fe species in the pyrolysis of Fe phthalocyanine and phenolic resin for preparation of carbon-based cathode catalysts,” which appeared in August 2010: Continue reading “False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

Author retracts FASEB Journal paper for data reuse

fasebThe FASEB Journal has retracted a 2012 paper by a group from the University of Alabama, Birmingham (UAB), looking at the role of a tumor-suppressing micro-RNA in pulmonary fibrosis. The retraction suggests the provenance of the data are in question, and we learned details of what went wrong.

Here’s the notice, which, sadly, is behind a $12-per-day paywall: Continue reading Author retracts FASEB Journal paper for data reuse

ORI says Case Western skin scientist falsified data

molbiolcelldoreianThe U.S. Office of Research Integrity has sanctioned Bryan William Doreian, a former postdoc in dermatology at Case Western Reserve University in Cleveland, for falsifying data in his dissertation and a 2009 paper in Molecular Biology of the Cell (for which it provided a cover image, at right).

ORI says Doreian’s bad NIH-funded data also appeared in a manuscript submitted to, but never published in, Nature Medicine.

Here are the papers cited in the finding: Continue reading ORI says Case Western skin scientist falsified data

“Unreliable” findings fell TB gene study in PLOS ONE

plosoneHere’s a nice example of how science should work.

A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule.

Here’s the retraction notice for the article, “A β-lactamase based reporter system for ESX dependent protein translocation in mycobacteria,” which has been cited once, according to Thomson Scientific’s Web of Knowledge: Continue reading “Unreliable” findings fell TB gene study in PLOS ONE

C-section study retracted for being a twin

doveA group of surgeons in Cairo, Egypt have retracted their 2012 paper in the International Journal of Women’s Health for plagiarism, although that’s not quite what they’re calling it.

Here’s the notice: Continue reading C-section study retracted for being a twin

Salami slicing in pork research leads to retractions

foodprotectionWe get accused of grabbing at cheap puns around here, but the headline above is meant to be taken straight up.

Three journals in the food sciences are retracting a trio of papers published last year on bacterial contamination in pork products because the articles used the same data sets — a classic (Platonic?) case of “salami slicing.”

The Journal of Food Protection, which published one of the articles, “Performance of three culture media commonly used for detecting Listeria monocytogenes,” has the following retraction notice:

Continue reading Salami slicing in pork research leads to retractions

Authors “regretfully” retract genomics paper for plagiarism

jasbcoverAuthors of a 2012 article in the Journal of Animal Science and Biotechnology have retracted it for plagiarism. 

The article, “Progress of genome wide association study in domestic animals,” came from a group of chicken geneticists in China affiliated with the Ministry of Agriculture in Harbin and Northeast Agricultural University, in the same city.

According to the retraction notice: Continue reading Authors “regretfully” retract genomics paper for plagiarism

Stapel watch reaches 45 retractions

stapel_npcKeeping up with the retraction count of Diederik Stapel is proving to be a, well, staple of this job. Four more retractions brings the figure to 45.

The articles in question are: Continue reading Stapel watch reaches 45 retractions

Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation

jmm113coverBharat Aggarwal, the highly cited MD Anderson Cancer Center researcher who has confirmed to us that his work is under investigation by the institution, has a correction of his work in the Journal of Molecular Medicine. Troubled images are to blame — as they have been in previous retractions, and at least one other correction, of Aggarwal’s papers.

The paper, “Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor,” was published in December 2010 and cited 15 times since, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice: Continue reading Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation

Hey authors, “Renewable Energy” doesn’t mean you can recycle words

renewableenergycoverRenewable Energy may cover conservation, but that doesn’t mean it expects its authors to recycle their own words. The Elsevier journal is retracting a biodiesel paper it published in February 2012 by a group of Chinese researchers who published much the same work in another title a month later. That periodical, the Journal of the American Oil Chemists Society, from Springer, has retracted its version as well.

Here’s the notice in Renewable Energy: Continue reading Hey authors, “Renewable Energy” doesn’t mean you can recycle words